Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,445 | -17,450 | -12,994 | -8,792 | -3,836 |
| Depreciation Amortization | 251 | 1,142 | 914 | 608 | 332 |
| Accounts payable and accrued liabilities | 236 | 869 | 1,214 | 238 | -16 |
| Other Working Capital | -1,121 | 1,933 | 1,890 | 1,781 | 521 |
| Other Operating Activity | -178 | -458 | -955 | -41 | 104 |
| Operating Cash Flow | $-4,257 | $-13,964 | $-9,931 | $-6,206 | $-2,895 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -47 | -504 | -386 | -266 | -65 |
| Sale Of Investment | N/A | 3,294 | 1,222 | -36 | -37 |
| Purchase Sale Intangibles | -145 | -258 | -187 | -120 | -75 |
| Other Investing Activity | -145 | -258 | -185 | -118 | -75 |
| Investing Cash Flow | $-192 | $2,532 | $651 | $-420 | $-177 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -7 | -34 | -24 | -18 | -11 |
| Common Stock Issued | 5,242 | 12,817 | 9,763 | 8,458 | 6,385 |
| Other Financing Activity | 0 | 2 | 0 | 0 | 0 |
| Financing Cash Flow | $5,235 | $12,785 | $9,739 | $8,440 | $6,374 |
| Beginning Cash Position | 2,156 | 803 | 803 | 803 | 803 |
| End Cash Position | 2,942 | 2,156 | 1,262 | 2,617 | 4,105 |
| Net Cash Flow | $786 | $1,353 | $459 | $1,814 | $3,302 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,257 | -13,964 | -9,931 | -6,206 | -2,895 |
| Capital Expenditure | -47 | -504 | -386 | -266 | -65 |
| Free Cash Flow | -4,304 | -14,468 | -10,317 | -6,472 | -2,960 |